title: Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.
authors.affiliation: Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
authors.forename: Chang-Fu
authors.initials: CF
authors.lastname: Kuo
authors.affiliation: Division of Epidemiology and Public Health, University of Nottingham, Nottingham, England.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Grainge
authors.affiliation: Arthritis Research UK Primary Care Centre, Keele University, Keele, England.
authors.forename: Christian
authors.initials: C
authors.lastname: Mallen
authors.affiliation: Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, England.
authors.forename: Weiya
authors.initials: W
authors.lastname: Zhang
authors.affiliation: Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, England.
authors.forename: Michael
authors.initials: M
authors.lastname: Doherty
mesh_terms: D004739:England; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006074:Gout Suppressants / Q000627:therapeutic use*; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D014527:Uric Acid / Q000378:metabolism
chemical_list: D006074:Gout Suppressants; D014527:Uric Acid